B cells implicated in triggering immunotherapy-related colitis, study finds

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new role for B cells in initiating and maintaining colitis caused by immune checkpoint inhibitors, a common cancer immunotherapy. This finding sheds light on the mechanisms behind this side effect and could inform future treatments to mitigate it.

Originally published by gnews